Pharmamarketeer

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

SARS-CoV-2

A new study sheds light on the potential of drug combinations to stem viral transmission and treat patients with COVID-19. It also shows that four drugs used to treat hepatitis C synergize with remdesivir to make it up to ten times more effective at inhibiting SARS-CoV-2 in cell cultures.

Advertentie(s)